Cryptococcus neoformans is an opportunistic fungal pathogen that causes life-threatening meningitis most commonly in populations with impaired immunity. Here, we resolved the transcriptome of the human brain endothelium challenged with C. neoformans to establish whether C. neoformans invades the CNS by co-opting particular signalling pathways as a means to promote its own entry. Among the 5 major pathways targeted by C. neoformans, the EPH-EphrinA1 
Cryptococcus neoformans is the leading cause of fungal meningitis and accounts for 15% of AIDS-related deaths worldwide (Rajasingham et al., 2017) . The global incidence of cryptococcal meningitis (CM) has been estimated at 223,100 resulting in 181,100 annual fatalities with approximately 73% of all cases occurring in sub-Saharan Africa (Rajasingham et al., 2017) . CM continues to cause significant morbidity and mortality in the United States. Of the 30,840 hospitalisations attributed to CM between 1997 and 2009, approximately 3,440 deaths were reported (Pyrgos, Seitz, Steiner, Prevots, & Williamson, 2013) . Of all the CM cases, 21.6% occurred among human immunodeficiency virus (HIV)-uninfected patients, and although a steady decline in the HIV-infected deaths was observed, the persistent burden of CM among HIV-uninfected patients is concerning (Pyrgos et al., 2013) .
Indeed without rapid intervention, CM is universally fatal regardless of the immune status of the host.
Several studies have shown that C. neoformans can move freely within the bloodstream, lodge within the lumen of the capillaries, and cross the BBB directly via a transcellular mechanism (Chang et al., 2004; Chen et al., 2003; Chretien et al., 2002; Jong, Wu, Prasadarao, et al., 2008; Shi et al., 2010; Vu, Weksler, Romero, Couraud, & Gelli, 2009 ).
Here, cryptococci adhere to and are internalised by the brain endothelium from the luminal (apical) side. Subsequently, fungal cells transmigrate through the endothelial cytoplasm, exit on the abluminal (basolateral) side of the BBB, and invade the brain parenchyma. This is an extraordinary achievement given that a crucial function of the BBB is to protect the brain from harmful agents. Cryptococci can breach the endothelium through an active process via protein-mediated transcytosis events that require C. neoformans viability, several fungal and host gene products including a metalloprotease (Mpr1), urease, CD44, and cytoskeleton remodelling of brain endothelial cells (Chang et al., 2004; Chen et al., 2003; Kim, Crary, Chang, Kwon-Chung, & Kim, 2012; T. B. Liu et al., 2013; Vu et al., 2014; Vu, Eigenheer, Phinney, & Gelli, 2013) . More recent evidence suggests that C. neoformans can also breach the BBB through a stealth-like mechanism by co-opting monocytes (Charlier et al., 2009; Santiago-Tirado, Onken, Cooper, Klein, & Doering, 2017) .
Despite the growing knowledge about fungal gene products that play a role in the trans-cellular crossing of the BBB, the identity and details of key signalling pathways in the brain endothelium that mediate the transcellular movement of cryptococci into the CNS are just beginning to be unravelled. In C. neoformans, capsule-bound hyaluronic acid serves as a ligand for the CD44 host receptor (Jong et al., 2007; Jong, Wu, Shackleford, et al., 2008; Jong et al., 2012) . Knockdown of CD44 in human brain microvascular endothelial cells (hCMEC) significantly reduced the adherence of C. neoformans demonstrating that CD44 acts as a receptor for hyaluronic acid in C. neoformans (Jong, Wu, Shackleford, et al., 2008; Jong et al., 2012) . In addition, mice deficient in CD44 (CD44 knockout mice) showed improved survival and less brain fungal burden further supporting a role for CD44 in the attachment of cryptococci to the BBB (Jong, Wu, Shackleford, et al., 2008) .
Invasion of C. neoformans into the brain endothelium requires the reorganisation of the actin cytoskeleton (Chang et al., 2004; Chen et al., 2003; Vu et al., 2009) . Studies involving scanning electron microscopy have shown that following binding of C. neoformans, hCMEC produce microvilli that envelop and internalise C. neoformans by a zipper-like mechanism (Chang et al., 2004) . The rearrangement of actin filaments plays a crucial role during internalisation because this produces the force required to generate the microvilli that engulf C. neoformans. Similar mechanisms have been shown to mediate the internalisation of other pathogens . The remodelling of actin filaments is mediated by the small GTPases-RhoA, Rac1, and Cdc42, many of which have been shown to play a role in the internalisation of C. neoformans and other pathogens Kim et al., 2012) .
Recent studies have demonstrated that some pathogens such as Chlamydia trachomatis, hepatitis C virus, Kaposi's sarcoma-associated herpes virus (KSHV), and Plasmodium sporozoites invade host cells by engaging EphA2, a tyrosine kinase receptor (TKR; Dutta et al., 2013; Kullander & Klein, 2002; Lupberger et al., 2011; Subbarayal et al., 2015) . EphA2 belongs to the Ephrin (EPH) family of TKR, and along with their membrane-tethered ligands (knows as ephrins), they make up the largest TKR subfamily (Kullander & Klein, 2002) .
The EphA2 receptor binds to glycosylphosphatidylinositol anchor (GPI)-linked ephrinA1 ligand and mediates diverse cellular activities including cytoskeleton remodelling, endothelial cell barrier integrity, cell adhesion, and motility and is also implicated in neovascularization and oncogenesis (Carter, Nakamoto, Hirai, & Hunter, 2002; Kullander & Klein, 2002; Pasquale, 2005) . The binding of ephrinA1 to EphA2 induces dimerisation and phosphorylation of EphA2 triggering signalling events mediated by PI3K, MAPK, Src kinases, Rac1, and Rho GTPases (Kullander & Klein, 2002) . EphA2 is unique among other TKRs, in that ligand binding to EphA2 produces reverse signalling in cells where the ligand is bound to the cell membrane (Pasquale, 2005) . A crystal structure of the ligand-binding domain of EphA2 and ephrinA1 suggested that EphA2 undergoes only minor conformational changes upon ephrinA1 binding indicating that the ephrinA1-binding pocket on EphA2 is formed prior to ligand binding, consistent with the "lock and key" model (Himanen et al., 2009; Petty et al., 2012) .
The extracellular portion of EphA2 consists of an N-terminal glycosylated ligand-binding domain, a region rich in cysteines and two fibronectin type III repeats. The cytosolic portion of EphA2 mediates protein-protein interactions through its SAM motif, a PDZ binding motif, and its kinase domain (Pasquale, 2005) .
In this study, we characterised the transcriptome of hCMEC challenged with C. neoformans in an in vitro model of the BBB. We mapped the transcriptome to known canonical signalling pathways according to the ratio of differentially expressed transcripts to the total number of genes attributed to each pathway. We identified the EPH-EphrinA1 (EphA2) TKR-signalling pathway and found that the EphA2 receptor mediated the migration of C. neoformans across the BBB in a CD44-dependent manner. Silencing the EphA2 transcript or inhibiting EphA2 activity with an antibody or an inhibitor (dasatinib) prevented C. neoformans from crossing the BBB, whereas activation of EphA2 with the ephrinA1 ligand or an agonist (doxasozin) enhanced crossing of C. neoformans. The EphA2 receptor was phosphorylated during C. neoformans infection, but phosphorylation was prevented by dasatinib, consistent with less cryptococci crossing brain endothelial cells when treated with dasatinib. Localisation studies of C. neoformans and EphA2 in human brain endothelial cells, live-cell recording of HEK293T cells expressing EphA2, and protection assays demonstrated a clear association between cryptococci and EphA2 consistent with a role for EphA2 during internalisation of C. neoformans. Collectively, the data suggest that C. neoformans engages the EphA2 receptor in order to cross the BBB.
2 | RESULTS 2.1 | The transcriptome of hCMEC challenged with C. neoformans suggests a role for the EphA2 TKRsignalling pathway
We sought to define the transcriptional response of the human BBB when challenged with C. neoformans. In order to capture the transcriptome representing the initial interface between hCMEC (a.k.a.
the BBB) and fungal cells, a strain of C. neoformans and a hCMEC line (hCMEC/D3, referred to as brain endothelial cells throughout the text) were coincubated for 3 hr ( Figure S1 ). This cell line recapitulates many features of primary hCMEC, and thus, the cell line has been used as a model of the human BBB (Poller et al., 2008; Weksler et al., 2005) . This time point was chosen based on previous studies demonstrating that attachment with concomitant changes in cell surface morphology occurred by 3 hr (Y. C. Chang et al., 2004; Chretien et al., 2002; Vu et al., 2009 ). We identified a total of 1,525 transcripts with a log 2 (fold-change) value >1.5-this represented approximately 3% of the entire transcripts in brain endothelial cells. Among the differentially expressed genes, 56% were upregulated and 44% were downregulated (Figure 1a ). Twelve genes identified by RNAseq were randomly selected and validated by quantitative PCR (Table S1 ). We also found that gene expression profiles of brain endothelial cells grown on either transwells or on 25 cm 2 flasks were similar (data not shown). (Table 1) . Several ion channels including ASIC3 acid sensing (proton-gated) channel, CACNG8 calcium channel, and KCNN2 potassium channel were also upregulated, whereas the CLIC4 chloride channel was downregulated (Table 1) . Collectively, these changes were indicative of shifts in metabolism and pH regulation induced by interactions with fungal cells.
Mapping the transcriptome to known canonical signalling pathways using Ingenuity Pathway Analysis (IPA, Qiagen, Inc.) revealed that five unique pathways dominated the transcriptome (Table 2) .
These included the EphA2 TKR pathway, axonal guidance pathway involving MAPK signalling and cytoskeleton regulation, RhoGDI (Rho GDP-dissociation inhibitors are important regulators of RhoGTPases in cytoskeleton-remodelling, vesicular trafficking, and gene expression), CXCR4-pathway (immune/inflammatory response), and IL-8 (interleukin-8) signalling pathway (cell proliferation, survival, and invasion; Table 2 ). Of the five pathways identified, approximately 11.49% (20 genes) of the 174 genes known to function within the EphA2-signalling pathway were differentially regulated in brain endothelial cells exposed to C. neoformans (Table 2) .
2.2 | The transmigration of C. neoformans is dependent on the expression of the EphA2-TKR in brain endothelial cells
The transcriptome analysis indicated a likely role for EphA2-signalling pathway in mediating the fungal-brain endothelium interaction. 
| C. neoformans activates EphA2 in brain endothelial cells by promoting its phosphorylation
We next examined whether the association of C. neoformans with brain endothelial cells could stimulate EphA2 activity. It is well established that EphA2 is activated through phosphorylation-this is a key step for receptor signalling and internalisation (Fang, Brantley-Sieders, Hwang, Ham, & Chen, 2008; Subbarayal et al., 2015) . To test this, brain The top canonical signalling pathways are mapped according to the ratios of differentially expressed genes (DEGs) to the total number of genes attributed to the pathway and the corresponding p value. N-terminal region of EphA2 (Petty et al., 2012) . Based on our observations above, we would predict a similar increase in fungal crossing.
As expected, the migration of fungal cells across the BBB was significantly enhanced in the presence of doxazosin (Figure 5b ). Thus, although inhibiting EphA2 activity prevented the migration of C. neoformans, we found that stimulating EphA2 activity with a ligand or an agonist enhanced crossing. In addition, clusters of the EphA2 receptor were observed in adjacent cells that were in proximity to C. neoformans (Figure 6b 
| EphA2 actively stimulates the internalisation of C. neoformans
Collectively, the data supported a central role for EphA2 in mediating an association of C. neoformans with the host. However, in order to establish whether EphA2 acted directly to internalise C. neoformans, a cell protection assay was performed (Figure 9 ). In this assay, HEK293T cells overexpressing EphA2 were exposed to C. neoformans for 1.5 hr, subsequently washed away, and replaced with fluconazole, a static antifungal drug. Prior to this step, fluconazole activity was monitored to ensure HEK293T cells remained viable, whereas fungal cells were susceptible (Figure 9c,d ). If fungal cells had been internalised by the HEK293T, they would not be exposed to fluconazole and therefore would be free to replicate. Eventually, the HEK293T cellscontaining C. neoformans could be lysed and the contents plated for CFU determination (Figure 9a ). We detected significantly more CFUs from HEK293T overexpressing EphA2 than HEK293T cells alone (transformed with an empty plasmid), suggesting that EphA2 was directly responsible for the internalisation of C. neoformans (Figure 9b ).
| EphA2-mediated transmigration of C. neoformans may be dependent on CD44
It was previously shown that the downregulation of the CD44 receptor reduces the migration of C. neoformans across brain endothelial cells A polyclonal anti-phospho antibody to EphA2 was used to detect the phosphorylated form of EphA2. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control. (c) Endothelial cells treated with dasatinib and coincubated with C. neoformans revealed a lack of EphA2 phosphorylation; however, dimethylsulfoxide (DMSO) control clearly indicated phosphorylated EphA2, thus consistent with the notion that C. neoformans activates EphA2. (d,f) Relative band intensity of phosphorylated EphA2 (Jong et al., 2012; Jong, Wu, Shackleford, et al., 2008) . To investigate the role of CD44 in the EphA2-mediated transmigration of C. neoformans, the cps1Δ deletion strain (Jong et al., 2007) was coincubated with recombinant ephrinA1 or doxazosin for 6 hr in transcytosis assays. The Cps1 gene encodes hyaluronic acid synthase, and deletion of Cps1 produces several phenotypes including a decreased ability to associate with brain endothelial cells. This defect is likely due to reduced hyaluronic acid, which serves as a ligand for CD44 (Jong et al., 2007) . We found that in contrast to the wild-type H99 strain, significantly less cps1Δ cryptococci crossed the BBB as previously reported (Figure 10a-d; Jong et al., 2007) , and the transmigration of cps1Δ was not enhanced by the addition of ephrinA1 or doxazosin (Figure 10a,b) . Interestingly, blocking the EphA2 receptor with an mAb or the inhibitor dasatinb completely prevented all crossing of cps1Δ cryptococci (Figure 10c,d) . We confirmed that the reduced migration of the cps1Δ strain was not due to a growth defect of the cps1Δ strain in endothelial medium (Figure 10e ), and we established that the integrity of the in vitro BBB was maintained throughout the transcytosis assays (Figure 10f-h) . Collectively, the data are consistent with the established role of CD44 (Jong, Wu, Shackleford, et al., 2008; Jong et al., 2012) but further implicate CD44 in the EphA2-mediated transmigration and support the notion that CD44 must be engaged to promote EphA2 activity.
| DISCUSSION
We have identified five signal transduction pathways in human brain endothelial cells that are targeted by C. neoformans. The EphA2 receptor, axonal guidance (related to EPH-signalling; Klein, 2012) , RhoGDI, CXCR4, and IL-8 (CXCL8) signalling pathways are significant because they contribute to an altered permeability of the BBB that can be transient or long lasting (Stamatovic, Keep, & Andjelkovic, 2008) . CXCR4 is a G-protein-coupled receptor that selectively binds the chemokine ligand, CXCL12 (also known as stromal cell-derived factor 1), and subsequently activates signalling events that produce several biological responses including gene transcription, cell adhesion, and cell migration (Busillo & Benovic, 2007) . Studies have indicated that the brain endothelium serves as a source for CXCL12 and its receptor (CXCR4) suggesting that CXCL12 can recruit CXCR4+ circulating lymphocytes and also act as a potential feedback mechanism for CXCR4 expression at the BBB (Holman, Klein, & Ransohoff, 2011) . This is consistent with our results where C. neoformans induced the expression of the CXCL12 transcript and promoted CXCR4-mediated signalling in brain endothelial cells. This finding is particularly interesting because it further supports the notion that C. neoformans might also transmigrate the BBB by a Trojan horse mechanism via infected phagocytes (Charlier et al., 2009; Santiago-Tirado et al., 2017; Sorrell et al., 2016) .
IL-8 found prestored in microvascular endothelial cells also stimulates G-protein-coupled signal transduction pathways that promote integrin-mediated adhesion of neutrophils (Russo, Garcia, Teixeira, & Amaral, 2014) . High levels of IL-8 were found in CSF of patients with CM, and some evidence suggested the cryptococcal capsular polysaccharide glucuronoxylomannan induced IL-8 production in the brain (Lipovsky et al., 1998) . A recent study found that endothelin-1, a potent vasoconstrictor, induced the production of IL-8 in human brain-derived endothelial cells and both altered BBB permeability (Hofman et al., 1998; Stamatovic et al., 2008) . We found that C. neoformans increased transcript levels of endothelin-1 and -2 and gene name for endothelin-1 receptor protein (EDNRA) (receptor for endothelin-1) consistent with the induction of IL-8-mediated signalling pathway.
The RNAseq analysis revealed several interesting aspects of how brain endothelial cells perceive and respond to fungal challenge. Our data point to changes in transcripts that would suggest significant endothelial cell stress such as the upregulation of the amyloid-beta Transcytosis assay revealed that the EphA2 agonist, doxazosin, facilitated migration of C. neoformans across brain endothelial cells. Dimethylsulfoxide (DMSO), a solvent for doxazosin and used here as a negative control, had no effect. Brain endothelial cells were exposed to 100 μM doxazosin and coincubated with 2 × 10 5 cells of C. neoformans. The binding of EphA2 to its ephrinA1 ligand induces receptor dimerisation and subsequent trans-phosphorylation through the cytoplasmic domains of the receptors (Kullander & Klein, 2002) . Interestingly, we found that silencing the ephrinA1 ligand in brain endothelial cells did not affect the transmigration of C. neoformans suggesting that the effect of EphA2 on fungal entry might be ligand-independent;
however, we also observed significant increases in the traversal EphA2 activity has been implicated in the reorganisation of the actin cytoskeleton through activities of GTPases such as Rho, Rac, and Cdc42 (Pitulescu & Adams, 2010) . Rho and Rac, both members of Ras-related superfamily of small GTPases, regulate actin polymerisation to produce stress fibres and lamellipodia, respectively (Nobes & Hall, 1995; Ridley, 2006) . Cdc42, another member of the Rho family, triggers formation of actin-based protrusions called filopodia (Nobes & Hall, 1995; Ridley, 2006 regulated by the activities of Rho-GTPases (RhoA, Rac1, and Cdc42), FAK, ezrin, and PKCα in the host (Kim et al., 2012) .
In the RNAseq analysis, we identified 27 transcripts related to cell signalling, including a Rho-GTPase activating protein 9 (Rho-GAP9), Rho-GEF4, and phospholipase A2. Interestingly, the RhoGAP 9 has substantial GAP activity towards Cdc42, Rac1, and RhoA (Moon & Zheng, 2003; Peck, Douglas Gt, & Burbelo, 2002) ; thus, it may serve as a master regulator in brain endothelial cells challenged with C. neoformans. Once activated, downstream events would include cytoskeleton remodelling (Furukawa et al., 2001) , which is consistent with our observations of altered cytoskeleton-related transcripts. Thus, our data strongly support the involvement of EphA2-mediated signalling events during the internalisation and transcytosis of C. neoformans by brain endothelial cells. Based on these studies, we propose that by activating EphA2-mediated signalling, C. neoformans can take advantage of the increased permeability of the BBB that results from changes in the cytoskeleton and the concomitant increase in endocytotic events.
Interestingly, some reports have suggested that EphA2 activation can increase paracellular permeability in endothelial cells by altering both tight and adherens junctions Larson, Schomberg, Schroeder, & Carpenter, 2008; Miao et al., 2014; Tanaka, Kamata, & Sakai, 2005) . Although the traversal of cryptococci in the in vitro model of the BBB did not appear to breakdown intercellular junctions of the barrier, we detected changes in expression of transcripts that mediate endothelial cell connections (claudin, cadherin)
including vasogenic agents (endothelin-1 and -2), thus suggesting an altered BBB permeability. We have found that longer coincubation times produce lower TEER values and greater dextran permeability suggesting that the observed hyper-permeability of the BBB may be a result of a weakened barrier. These observations are consistent with a previous study where we demonstrated that human brain endothelial cells challenged with C. neoformans can undergo significant molecular and cellular changes indicative of BBB injury (Vu et al., 2013) . These changes included the translocation of High Mobility Group Box 1 protein (HMGB1), a marker of cell injury, the upregulation of cyclophilinA, and the downregulation of proteins that function in energy production, protein processing and transcription (Vu et al., 2013) . In addition, studies have shown that cryptococcal infection can cause disruption and remodelling of tight junction proteins, ZO-1 and occludin (Jong et al., 2007; T. B. Liu et al., 2013) . Furthermore, histological analysis of blood-to-brain invasion of cryptococci demonstrated capillary damage where the presence of fungal cells in small capillaries led to structural changes in microvessel walls next to ruptured microcapillaries (Olszewski et al., 2004) . This is consistent with in vivo studies that found the BBB significantly breached by 24-hr postinfection as demonstrated by leakage of horseradish peroxidase (Charlier et al., 2005) . The crossing of the BBB occurred in the cortical capillaries and caused severe damage to the microvessels (Charlier et al., 2005) .
A recent in vivo study demonstrated that EphA2 receptor activation worsened ischaemic brain injury in mice by promoting BBB damage (Thundyil et al., 2013) . Mice lacking EphA2 faired much better suggesting that the absence or inactivation of EphA2 activity may FIGURE 9 EPH-EphrinA1 (EphA2) is responsible for the internalisation of Cryptococcus neoformans in HEK293T that overexpress EphA2. (A) To establish whether EphA2 acted directly to internalise C. neoformans, a cell protection assay was performed. HEK293T cells overexpressing EphA2 were exposed to C. neoformans for 1.5 hr, subsequently washed away and replaced with fluconazole (15 μg/ml), a static antifungal drug. Following a further 48-hr coincubation where internalised C. neoformans was protected from fluconazole and allowed to replicate, HEK293T cells were lysed and plated for CFU determination. (b) Significantly more CFUs from HEK293T overexpressing EphA2 than HEK293T cells alone (transformed with an empty plasmid) were detected, suggesting that EphA2 was directly responsible for the internalisation of C. neoformans. (c,d) Prior to the assay, fluconazole activity was monitored to ensure HEK293T cells remained viable and fungal cells were susceptible serve a protective role, thus making EphA2 an attractive drug target (Barquilla & Pasquale, 2015; Thundyil et al., 2013; Zhou et al., 2011) .
In the case of C. neoformans, prolonged activity of EphA2 could conceivably alter and/or weaken endothelial cell junctions and thereby promote paracellular permeability. Given that patients with meningoencephalitis caused by C. neoformans eventually experience significant brain oedema, the movement of excess fluid into the brain is likely occurring via disrupted tight junctions in a weakened barrier and thus fungal cells may ultimately take advantage of this opening into the brain. The notion that EphA2 could function to couple an initial transcytosis event with an eventual paracellular opening is intriguing and worth further exploration.
The roles of EphA2 and CD44 in promoting the transcellular migration of C. neoformans across the BBB may not be incongruous because it is conceivable that both receptors may work in unison.
Indeed, both CD44 and EphA2 have been implicated in regulating p < 0.01, *** p < 0.0001, n/s = not significant the endothelial cell barrier and angiogenesis (Lennon et al., 2014) . A recent study found that treating endothelial cells with low molecular weight hyaluronan induced the association of CD44v10 (a variant of CD44) with EphA2 and the concomitant activation of EphA2 via phosphorylation, thus suggesting a cross-talk between EphA2 and CD44 (Lennon et al., 2014) . Furthermore, the CD44-EphA2 complex facilitated recruitment of several proteins needed to induce RhoA activation during angiogenesis (Lennon et al., 2014) .
In the case of C. neoformans, the inability of the cps1Δ strain to induce the phosphorylation of EphA2 or to cross the BBB upon stimulating EphA2 supports the notion that CD44 must be engaged in order to promote the EphA2-mediated transmigration of cryptococci. The working model (Figure 11 ) proposes that C. neoformans associates with CD44 on the luminal (apical) side of the brain endothelium and induces EphA2 phosphorylation via CD44-mediated transactivation of EphA2.
Interestingly, despite the lack of Cps1, some transmigration of cps1Δ cryptococci still occurred, albeit to a lesser extent. This may reflect an incomplete lack of hyaluronan in the cps1Δ strain or alternatively a CD44-independent transmigration path may also exist. Once activated, EphA2 promotes GTPase-dependent signalling that reorganises the actin cytoskeleton and internalises C. neoformans via endocytosis.
Subsequently, the transcellular movement of C. neoformans across brain endothelial cells would be dependent on the activity of Annexin A2 and other signalling events (Na Pombejra, Salemi, Phinney, & Gelli, 2017) . Sustained EphA2 activation could alter the integrity of the BBB by weakening intercellular junctions thereby boosting further entry of C. neoformans and fluid, resulting in brain oedema Miao et al., 2014; Tanaka et al., 2005; Thundyil et al., 2013) .
In summary, this study makes a significant contribution to resolving the complicated tactics used by fungal pathogens to breach the BBB (Tanaka et al., 2005) (Weksler et al., 2005; Weksler, Romero, & Couraud, 2013) . hCMEC/ D3 cells were maintained in a 25 cm 2 flask as previously described (Vu et al., 2009; Weksler et al., 2005) . 4.3 | Total RNA isolation, cDNA library preparation, and RNA sequencing
The total RNA were isolated using RNeasy Mini Kit (Qiagen). The hCMEC/D3 was harvested and washed three times. Total RNA from hCMEC/D3 samples was isolated then subjected to sample quality assessments utilising both Nanodrop and Agilent Biolanalyzer analysis. Samples were not submitted for mRNA isolation until the sample RNA integrity number score was greater than 7 and the 28S and 18S rRNA peaks were observed. The mRNA samples were used to prepare cDNA libraries then sequenced on the Illumina HiSeq platform (RNA-Seq). The transcriptomic profiles were retrieved from mapping the short reads to the reference genome. In our study, human genome database Hg19 from HUGO was used as the reference genome. Statistics were run on all samples, using the Bioconductor package edgeR. Differentially 
| RNA sequencing validation by quantitative polymerase chain reaction (PCR)
The hCMEC/D3 cells were grown and infected with C. neoformans (H99) as described in the protocol above, but instead of the 75 cm 2 flask, the 25 cm 2 flask was used. hCMEC/D3 cells were harvested, and the total RNA was isolated by using RNeasy kit as described above. Total RNA was used to generate cDNA with the Quantitect Reverse Transcription kit (Qiagen). Expression levels of 12 genes were analysed using quantitative-PCR as a validation of RNA-seq (Table S1 ).
The cDNA samples were diluted to 20 ng/μl. Gene-specific primers were used (Table S2 ). All quantitative-PCR reactions were performed in 96-well plates using the ABI 7700 sequence detection system (Perkin-Elmer Applied Biosystems), and the amplifications were done using the SYBR Green PCR Master Mix (Applied Biosystems). The thermal cycling conditions were 50°C for 2 min followed by an initial denaturation step at 95°C for 10 min, 45 cycles at 95°C for 30 s, 
| Statistical analysis
Statistical significance was determined by unpaired Student's t-test with Welch's correction or running ANOVA using GraphPad Prism Program (GraphPad Software Inc.). p values <0.05 were considered significant.
